1. Home
  2. Browse Decisions
  3. Cal.Rptr.3d
  4. 48 Cal.Rptr.3d
  5. 48 Cal.Rptr.3d 668 (2006)
 

NELSON v. INDEVUS PHARMACEUTICALS, INC.

No. B183942.

48 Cal.Rptr.3d 668 (2006)

142 Cal.App.4th 1202

Paula NELSON, Plaintiff and Appellant, v. INDEVUS PHARMACEUTICALS, INC., Defendant and Respondent.

Court of Appeal of California, Second District, Division Five.

September 12, 2006.

Attorney(s) appearing for the Case

Hackard & Holt and Theodore J. Holt and Peter T. Holt, Gold River, for Plaintiff and Appellant.

Skadden, Arps, Slate, Meagher & Flom LLP and Raoul D. Kennedy, San Francisco; and Katherine Armstrong, pro hac vice, for Defendant and Respondent.

Certified for Partial Publication.*

ARMSTRONG, J.

This lawsuit arises from plaintiff and appellant Paula Nelson's use of the prescription diet drug dexfenfluramine (sold as Redux), which was promoted and marketed by defendant and respondent Indevus. Redux and a similar drug, Pondimin (both commonly known as "Fen-phen") were withdrawn from the market in September of 1997, on reports...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases